Franklin Resources
ZNTL icon

Franklin Resources’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Franklin Resources’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-106,748
Closed -$323K – 3083
2024
Q4 		$323K Buy
+106,748
New +$350K ﹤0.01% 2479
2021
Q2 		– Sell
-327,197
Closed -$14.2M – 2080
2021
Q1 		$14.2M Hold
327,197
– – 0.01% 911
2020
Q4 		$17M Buy
327,197
+152,112
+87% +$6.86M 0.01% 851
2020
Q3 		$5.72M Buy
175,085
+35
+0% +$1.23K ﹤0.01% 1024
2020
Q2 		$7.38M Buy
+175,050
New +$6.71M ﹤0.01% 935

Other funds holding ZNTL

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources's ZNTL Position: Q1 2025 in Review

Franklin Resources sold out of Zentalis Pharmaceuticals (ZNTL) in Q1 2025, closing a stake of 106,748 shares — an estimated $323K sold.

Franklin Resources first reported a position in ZNTL in Q2 2020 and held it in 5 quarters. The position peaked at $17M in Q4 2020. 132 funds tracked by Wall St. Rank hold ZNTL as of Q1 2025.

  • Franklin Resources reported no remaining Zentalis Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Franklin Resources sold 106,748 Zentalis Pharmaceuticals shares in Q1 2025, an estimated $323K.
  • Franklin Resources first reported a position in Zentalis Pharmaceuticals in Q2 2020 and held it in 5 quarters.
  • Franklin Resources's Zentalis Pharmaceuticals position peaked at $17M in Q4 2020.
  • 132 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q1 2025.

Based on Franklin Resources's 13F filing for Q1 2025, filed 13 May 2025.